GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: International Journal of Molecular Sciences, MDPI AG, Vol. 24, No. 19 ( 2023-09-26), p. 14543-
    Abstract: Breast cancer (BC) is one of the biggest health problems worldwide, characterized by intricate metabolic and biochemical complexities stemming from pronounced variations across dysregulated molecular pathways. If BC is not diagnosed early, complications may lead to death. Thus, the pursuit of novel therapeutic avenues persists, notably focusing on epigenetic pathways such as histone deacetylases (HDACs). The compound N-(2-hydroxyphenyl)-2-propylpentanamide (HO-AAVPA), a derivative of valproic acid (VPA), has emerged as a promising candidate warranting pre-clinical investigation. HO-AAVPA is an HDAC inhibitor with antiproliferative effects on BC, but its molecular mechanism has yet to be deciphered. Furthermore, in the present study, we determined the metabolomic effects of HO-AAVPA and VPA on cells of luminal breast cancer (MCF-7) and triple-negative breast cancer (MDA-MB-231) subtypes. The LC-MS untargeted metabolomic study allowed for the simultaneous measurement of multiple metabolites and pathways, identifying that both compounds affect glycerophospholipid and sphingolipid metabolism in the MCF-7 and MDA-MB-231 cell lines, suggesting that other biological targets were different from HDACs. In addition, there are different dysregulate metabolites, possibly due to the physicochemical differences between HO-AAVPA and VPA.
    Type of Medium: Online Resource
    ISSN: 1422-0067
    Language: English
    Publisher: MDPI AG
    Publication Date: 2023
    detail.hit.zdb_id: 2019364-6
    SSG: 12
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Development, The Company of Biologists, Vol. 138, No. 6 ( 2011-03-15), p. 1093-1097
    Abstract: Epicardial-derived signals are key regulators of cardiac embryonic development. An important part of these signals is known to relate to a retinoic acid (RA) receptor-dependent mechanism. RA is a potent morphogen synthesised by Raldh enzymes, Raldh2 being the predominant one in mesodermal tissues. Despite the importance of epicardial retinoid signalling in the heart, the molecular mechanisms controlling cardiac Raldh2 transcription remain unknown. In the current study, we show that Wt1-null epicardial cells display decreased expression of Raldh2 both in vivo and in vitro. Using a RA-responsive reporter, we have confirmed that Wt1-null epicardial cells actually show reduced synthesis of RA. We also demonstrate that Raldh2 is a direct transcriptional target of Wt1 in epicardial cells. A secondary objective of this study was to identify the status of RA-related receptors previously reported to be critical to epicardial biology (PDGFRα,β; RXRα). PDGFRα and PDGFRβ mRNA and protein levels are downregulated in the absence of Wt1, but only Pdgfra expression is rescued by the addition of RA to Wt1-null epicardial cells. RXRα mRNA levels are not affected in Wt1-null epicardial cells. Taken together, our results indicate that Wt1 critically regulates epicardial RA signalling via direct activation of the Raldh2 gene, and identify a role for Wt1 in the regulation of morphogen receptors involved in the proliferation, migration, and differentiation of epicardial and epicardially-derived cells (EPDC).
    Type of Medium: Online Resource
    ISSN: 1477-9129 , 0950-1991
    Language: English
    Publisher: The Company of Biologists
    Publication Date: 2011
    detail.hit.zdb_id: 2007916-3
    SSG: 12
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Journal of Materials Chemistry A, Royal Society of Chemistry (RSC), Vol. 10, No. 20 ( 2022), p. 11298-11305
    Abstract: Halide perovskite materials (HPMs) have been recently employed as photocatalysts in H 2 generation, CO 2 reduction and organic synthesis. However, the high toxicity of lead is directing research towards Pb-free halide perovskites with bismuth as the main candidate to replace Pb. This contribution discloses the synthesis of two bismuth-based halide perovskites with chemical compositions Cs 2 AgBiBr 6 and Cs 3 Bi 2 Br 9 via a solvent-free mechanochemical process in a ball mill. The obtained perovskite powders were characterized via X-ray diffraction, scanning electron microscopy (SEM) and absorption and photoluminescence (PL) steady-state and time-resolved spectroscopy. Cs 2 AgBiBr 6 was able to absorb more in the visible region ( E g = 2.12 eV) as compared to Cs 3 Bi 2 Br 9 ( E g = 2.53 eV). Additionally, PL time decays were considerably longer for Cs 2 AgBiBr 6 ( τ av = 740 ns) with respect to Cs 3 Bi 2 Br 9 ( τ av = 0.3 ns). Both photo-systems were employed in the oxidation of vanillyl alcohol to vanillin, an aldehyde derivative, under UV or visible illumination. Moderate values of photocatalytic conversion (15–30%) were observed except for Cs 2 AgBiBr 6 under visible light irradiation, where 95% conversion could be obtained after only 80 minutes of exposition. PL measurements with the fluorescent probe hydroethidine and electron spin resonance (ESR) demonstrated the formation of superoxide radical species (˙O 2 − ) after photoexcitation, with a larger concentration observed for Cs 2 AgBiBr 6 under visible light due to higher absorption and longer lifetime of the photogenerated charge carriers. Time-resolved PL measurements of both catalysts mixed with vanillyl alcohol powder shed light on the oxidation step upon irradiation taking place due to a hole transfer process from the valence band of the catalysts.
    Type of Medium: Online Resource
    ISSN: 2050-7488 , 2050-7496
    Language: English
    Publisher: Royal Society of Chemistry (RSC)
    Publication Date: 2022
    detail.hit.zdb_id: 2702232-8
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: International Journal of Molecular Sciences, MDPI AG, Vol. 23, No. 20 ( 2022-10-11), p. 12074-
    Abstract: Breast cancer (BC) is the first malignant neoplasm in women, with a high death rate despite early diagnoses and treatment advances. Significant differences exist between the most common BC and triple-negative breast cancer (TNBC). TNBC presents molecular differences such as lacking expression of the estrogen receptor (ER), progesterone receptor (PR), and HER2 proteins, making this cancer have a poor clinical prognostic and lack clear strategies for its treatment. However, growing evidence points to metabolic dysregulation as another differential process between stages and types of BC. Therefore, the study of this crucial hallmark could identify new therapeutic targets to treat this aggressive form of BC. These differences induce an in vitro exploration of the metabolic behavior of the MCF7 cells (nTNBC) and MDA-MB-231 (TNBC) cells under lipidomic based LC–MS. The results show more significant differences in lipid regulation (phosphatidylethanolamine) that could be associated with the aggressiveness and difficulties of the treatment of TNBC.
    Type of Medium: Online Resource
    ISSN: 1422-0067
    Language: English
    Publisher: MDPI AG
    Publication Date: 2022
    detail.hit.zdb_id: 2019364-6
    SSG: 12
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...